ZNTL Zentalis Pharmaceuticals, Inc.

Fundamentals / CIK 0001725160 / USD

Zentalis Pharmaceuticals, Inc. reported $0 in revenue and a net loss of $141.7M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ZNTL in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$97.31M$48.65M$0-$278.9MFY 2019 Net Income: -$45.66M2019FY 2020 Net Income: -$117.8M2020FY 2021 Net Income: -$158.7M2021FY 2022 Revenue: $0FY 2022 Net Income: -$236.8M2022FY 2023 Revenue: $0FY 2023 Net Income: -$292.2M2023FY 2024 Revenue: $67.42MFY 2024 Net Income: -$165.8M2024FY 2025 Revenue: $0FY 2025 Net Income: -$137.1M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $0 $67.42M $0 $0 -- -- --
Research & Development $107.3M $167.8M $189.6M $172.7M $175.6M $84.90M $38.39M
Total Operating Expenses $152.8M $258.6M $299.5M $227.3M $216.5M $118.8M $46.84M
Operating Income -$152.8M -$191.2M -$299.5M -$227.3M -$216.5M -$118.8M -$46.84M
EBITDA -$152.1M -$189.9M -$298.1M -$225.9M -$216.0M -$118.6M -$46.73M
Income Before Tax -$136.6M -$165.7M -$292.9M -$237.6M -$166.4M -$118.1M -$46.36M
Income Tax Expense $442K $177K -$601K -$469K -$297K $444K $15K
Net Income -$137.1M -$165.8M -$292.2M -$236.8M -$158.7M -$117.8M -$45.66M
Basic EPS -$1.91 -$2.33 -$4.47 -$4.48 -$3.72 -$4.19 --
Diluted EPS -$1.91 -$2.33 -$4.47 -$4.48 -$3.72 -$4.19 -$8.16
Basic Shares Outstanding 71.9M 71.1M 65.4M 52.9M 42.7M 28.1M 5.6M
Diluted Shares Outstanding 71.9M 71.1M 65.4M 52.9M 42.7M 28.1M 5.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- $0 $0 $0 $0 $26.86M
Research & Development $22.33M $35.16M $28.72M $29.49M $22.95M $27.61M $27.25M $32.97M
Total Operating Expenses $31.15M $44.39M $37.85M $37.39M $33.73M $36.06M $45.62M $76.71M
Operating Income -$31.15M -$44.39M -$37.85M -$37.39M -$33.73M -$36.06M -$45.62M -$49.85M
EBITDA -$31.00M -$44.24M -$37.70M -$37.24M -$33.57M -$35.90M -$45.36M -$49.53M
Income Before Tax -$28.70M -$42.15M -$35.23M -$34.77M -$26.69M -$26.87M -$48.28M -$47.68M
Income Tax Expense $118K $138K $120K $442K $0 $0 $0 -$205K
Net Income -$28.82M -$42.29M -$35.35M -$35.22M -$26.69M -$26.87M -$48.28M -$47.47M
Basic EPS -$0.34 -$0.59 -$0.50 -- -$0.37 -$0.37 -$0.67 --
Diluted EPS -$0.34 -$0.59 -$0.50 -- -$0.37 -$0.37 -$0.67 --
Basic Shares Outstanding 84.6M 71.3M 70.3M -- 72.1M 72.0M 71.7M --
Diluted Shares Outstanding 84.6M 71.3M 70.3M -- 72.1M 72.0M 71.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $35.99M $33.90M $28.04M $43.07M $59.71M $54.95M $67.25M
Short-Term Investments $209.9M $318.0M $454.9M -- -- $283.6M --
Cash & Short-Term Investments $245.9M $351.9M $482.9M $43.07M $59.71M $338.5M $67.25M
Accounts Receivable, Net $0 $5.00M $0 -- $4.0K $417K $140K
Total Current Assets $253.2M $386.1M $496.7M $451.9M $350.8M $345.1M $68.89M
Property, Plant & Equipment, Net $2.77M $4.70M $5.82M $7.71M $8.15M $1.10M $501K
Goodwill -- $0 $3.74M $3.74M $3.74M $3.74M $3.74M
Intangible Assets -- -- -- -- -- $8.80M --
Total Non-Current Assets $35.78M $44.27M $54.97M $87.38M $103.7M $20.45M $18.59M
Total Assets $289.0M $430.3M $551.7M $539.3M $454.5M $365.6M $87.48M
Accounts Payable $7.21M $7.44M $14.93M $11.25M $11.59M $8.66M $4.29M
Total Current Liabilities $36.56M $52.73M $69.37M $56.65M $43.94M $28.60M $14.90M
Other Non-Current Liabilities $500K $849K $1.78M $2.62M $0 $1.10M $1.70M
Total Non-Current Liabilities $36.20M $40.43M $44.93M $48.64M $46.08M $3.58M $4.16M
Total Liabilities $72.76M $93.15M $114.3M $105.3M $90.03M $32.18M $19.06M
Total Debt (incl. Leases) $39.58M $42.65M $45.77M $47.33M $45.91M $2.00M $781K
Common Stock $69K $71K $70K $59K $45K $41K $0
Retained Earnings -$1.19B -$1.05B -$888.6M -$596.4M -$359.6M -$200.8M -$82.99M
Accumulated Other Comp. Income $196K $558K $2.19M -$1.35M -$125K $36K $0
Total Stockholders' Equity $216.2M $337.2M $437.3M $433.8M $364.0M $308.6M --
Total Equity $216.2M $337.2M $437.4M $434.0M $364.5M $333.4M -$73.28M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $24.03M $24.78M $31.93M $35.99M $39.07M $37.60M $41.93M $33.90M
Short-Term Investments $204.9M $149.8M $179.8M $209.9M $239.2M $249.0M $278.4M $318.0M
Cash & Short-Term Investments $228.9M $174.6M $211.8M $245.9M $278.3M $286.6M $320.3M $351.9M
Accounts Receivable, Net -- -- -- $0 $0 $0 $0 $5.00M
Total Current Assets $237.3M $181.3M $218.1M $253.2M $288.3M $311.6M $342.9M $386.1M
Property, Plant & Equipment, Net $2.35M $2.50M $2.65M $2.77M $2.93M $3.09M $3.25M $4.70M
Goodwill -- -- -- -- -- -- -- $0
Total Non-Current Assets $32.92M $34.05M $34.97M $35.78M $38.95M $40.11M $41.14M $44.27M
Total Assets $270.2M $215.3M $253.1M $289.0M $327.2M $351.7M $384.0M $430.3M
Accounts Payable $5.33M $8.14M $7.38M $7.21M $7.03M $3.72M $7.77M $7.44M
Total Current Liabilities $32.36M $37.63M $35.24M $36.56M $37.17M $39.02M $49.43M $52.73M
Other Non-Current Liabilities $500K $500K $500K $500K $500K $500K $558K $849K
Total Non-Current Liabilities $32.94M $34.06M $35.15M $36.20M $37.21M $38.19M $39.21M $40.43M
Total Liabilities $65.31M $71.68M $70.39M $72.76M $74.38M $77.21M $88.64M $93.15M
Total Debt (incl. Leases) $36.71M $37.69M $38.65M $39.58M $40.46M $41.32M $42.16M $42.65M
Common Stock $98K $72K $71K $69K $72K $72K $72K $71K
Retained Earnings -$1.30B -$1.27B -$1.23B -$1.19B -$1.16B -$1.13B -$1.10B -$1.05B
Accumulated Other Comp. Income -$495K -$78K -$50K $196K $186K $59K $358K $558K
Total Stockholders' Equity $204.9M $143.6M $182.7M $216.2M $252.9M $274.5M $295.4M $337.2M
Total Equity $204.9M $143.6M $182.7M $216.2M $252.9M $274.5M $295.4M $337.2M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$137.1M -$165.9M -$292.3M -$237.1M -$166.1M -$118.5M -$46.38M
Depreciation & Amortization $739K $1.29M $1.39M $1.43M $544K $160K $111K
Stock-Based Compensation $20.72M $67.27M $54.82M $46.84M $35.74M $23.15M $617K
Change in Receivables $5.00M -$5.00M $0 $0 $413K -$277K $777K
Operating Cash Flow -$125.2M -$170.9M -$207.8M -$163.8M -$154.1M -$86.83M -$39.14M
Capital Expenditure $0 -$221K -$583K -$2.55M -$6.11M -$758K -$352K
Free Cash Flow -$125.2M -$171.1M -$208.4M -$166.3M -$160.2M -$87.58M -$39.49M
Purchases of Investments -$139.5M -$128.0M -$549.2M -$533.2M -$363.5M -$401.0M $0
Investing Cash Flow $131.6M $176.6M -$44.46M -$114.2M -$18.11M -$284.8M -$352K
Common Stock Issued $5.39M $0 $235.7M $257.9M $172.0M $155.3M $0
Share Repurchases -$9.98M $0 $0 -- -- -- --
Financing Cash Flow -$4.28M $108K $237.3M $261.0M $178.5M $360.4M $81.83M
Net Change in Cash $2.09M $5.81M -$14.98M -$16.89M $6.31M -$11.22M $42.34M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$28.82M -$42.29M -$35.35M -$35.22M -$26.69M -$26.87M -$48.28M -$47.47M
Depreciation & Amortization $152K $152K $151K $157K $160K $160K $262K $317K
Stock-Based Compensation $3.21M $3.21M $3.20M $3.12M $4.83M $6.29M $6.49M $31.36M
Change in Receivables $0 $0 $0 -- $0 $0 $5.00M --
Operating Cash Flow -$32.71M -$37.24M -$32.96M -$30.94M -$26.96M -$34.71M -$32.64M -$39.70M
Capital Expenditure $0 $0 -$34K $0 $0 $0 $0 $0
Free Cash Flow -$32.71M -$37.24M -$32.99M -$30.94M -$26.96M -$34.71M -$32.64M -$39.70M
Purchases of Investments -$115.3M -$29.98M -$29.95M -$30.24M -$49.53M -$40.19M -$19.53M -$39.22M
Investing Cash Flow -$55.31M $30.02M $30.01M $32.45M $28.32M $30.38M $40.48M $32.28M
Financing Cash Flow $87.26M $65K -$1.12M -$4.59M $115K $0 $189K $0
Net Change in Cash -$754K -$7.15M -$4.07M -$3.08M $1.47M -$4.33M $8.03M -$7.42M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -283.6% -- -- -- -- --
Net Profit Margin -- -246.0% -- -- -- -- --
Return on Equity (ROE) -63.4% -49.2% -66.8% -54.6% -43.6% -38.2% --
Return on Assets (ROA) -47.4% -38.5% -53.0% -43.9% -34.9% -32.2% -52.2%
Current Ratio 6.93x 7.32x 7.16x 7.98x 7.98x 12.07x 4.62x
Quick Ratio 6.73x 6.77x 6.96x 0.76x 1.36x 11.85x 4.52x
Debt to Equity 0.18x 0.13x 0.10x 0.11x 0.13x 0.01x --
Revenue Growth (YoY) -100.0% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -- -- -615.2% -681.0% -789.3% -283.6%
Net Profit Margin -- -- -- -- -555.8% -605.9% -834.5% -246.0%
Return on Equity (ROE) -69.1% -97.1% -68.0% -63.4% -59.0% -59.3% -75.9% -49.2%
Return on Assets (ROA) -52.4% -64.8% -49.1% -47.4% -45.6% -46.3% -58.4% -38.5%
Current Ratio 7.33x 4.82x 6.19x 6.93x 7.76x 7.99x 6.94x 7.32x
Quick Ratio 7.07x 4.64x 6.01x 6.73x 7.49x 7.35x 6.48x 6.77x
Debt to Equity 0.18x 0.26x 0.21x 0.18x 0.16x 0.15x 0.14x 0.13x
Revenue Growth (YoY) -- -- -- -100.0% -- -- -100.0% --
Net Income Growth (YoY) -- -- -- -- -- -- -579.5% --
EPS Growth (YoY) -- -- -- -- -- -- -578.6% --
Source: SEC EDGAR CompanyFacts (CIK 0001725160) · from March 31, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:45 UTC · Open in terminal